What is greater plantain used for medicinally?

Greater Plantain is primarily used to treat respiratory conditions such as bronchitis, where clinical trials show it reduces cough frequency, sputum volume, and chest pain within 7–14 days. It is also applied topically to accelerate healing of wounds, burns, and diabetic foot ulcers, and is used traditionally to soothe irritated gastrointestinal mucosa due to its mucilage content.

What is the active compound in Plantago major?

The principal bioactive compound is aucubin, an iridoid glycoside that inhibits NF-κB-mediated inflammation and suppresses pro-inflammatory cytokines including TNF-α and IL-1β. Acteoside (verbascoside) is a secondary phenylpropanoid glycoside that contributes antioxidant and protein kinase C-inhibiting activity, while mucilaginous polysaccharides provide the demulcent and wound-protective effects.

What is the recommended dosage of greater plantain for bronchitis?

Clinical trials on respiratory benefits have used standardized aqueous-ethanolic extracts or syrups delivering approximately 510–600 mg of dry herb equivalent per dose, taken 3 times daily for 7–14 days. Exact dosing varies by preparation and standardization level; consumers should follow product-specific labeling and consult a healthcare provider, as no universally accepted therapeutic dose has been established by regulatory bodies.

Does greater plantain interact with any medications?

Yes — Plantago major's mucilage can slow intestinal absorption of drugs taken concurrently, with the most clinically significant concern being reduced bioavailability of warfarin, digoxin, and other narrow-therapeutic-index medications. It may also potentiate diuretic and antihypertensive drugs due to its own mild diuretic action; separating supplement doses from medications by at least 1–2 hours and monitoring relevant lab values is recommended.

Is greater plantain the same as psyllium?

No — although both belong to the Plantago genus, psyllium comes from Plantago ovata (and to a lesser extent P. psyllium), and its therapeutic use centers on its exceptionally high-fiber seed husk, which is FDA-approved for lowering LDL cholesterol and improving bowel regularity. Greater Plantain (Plantago major) is a broadleaf species whose medicinal value lies in its leaves containing aucubin, acteoside, and moderate mucilage, primarily targeting respiratory inflammation and wound healing rather than lipid or bowel management.

Is greater plantain safe to use during pregnancy and breastfeeding?

Greater plantain is traditionally considered safe during pregnancy and breastfeeding when used in culinary amounts, though clinical safety data specific to supplemental doses is limited. Pregnant and nursing women should consult their healthcare provider before taking concentrated extracts or high-dose supplements of plantain. Some herbalists recommend avoiding therapeutic doses during the first trimester as a precautionary measure.

What is the most effective form of greater plantain for respiratory health—fresh leaf, dried herb, or extract?

Clinical research on bronchitis shows the strongest evidence for standardized leaf extracts, which concentrate active compounds like aucubin and plantaioside; these demonstrated significant symptom reduction in RCTs. Fresh or dried leaf infusions (teas) are also traditionally effective and provide mucilage compounds that soothe airways, though with less standardized potency than extracts. For consistent results, a standardized extract taken at studied doses typically outperforms loose dried herb, though dried leaf preparations remain a practical alternative.

Who should avoid greater plantain supplements, and are there specific populations at higher risk for adverse effects?

People with allergies to plantain or related plants in the Plantaginaceae family should avoid supplementation; cross-reactivity with birch pollen allergens has been documented in some individuals. Those with bleeding disorders or taking anticoagulant medications should exercise caution, as plantain may have mild platelet-aggregating effects at high doses. Individuals with asthma or respiratory allergies should use plantain cautiously and monitor for any worsening of symptoms, particularly when starting supplementation.

Greater Plantain (Plantago major)

Greater Plantain (Plantago major) contains bioactive compounds including aucubin (an iridoid glycoside), acteoside, and mucilaginous polysaccharides that drive its therapeutic effects. Aucubin inhibits pro-inflammatory cytokine release and modulates NF-κB signaling, while mucilage forms a protective film on irritated mucous membranes to reduce cough and accelerate tissue repair.

Category: European Evidence: 2/10 Tier: Moderate

Greater Plantain (Plantago major) — Hermetica Encyclopedia

Origin & History

Greater Plantain (Plantago major) is a perennial herbaceous plant native to Europe and Asia, now widespread globally, belonging to the Plantaginaceae family. It is sourced from the leaves, seeds, or whole plant, with extracts typically prepared via hydroalcoholic extraction, decoction, or topical formulation standardized to compounds like quercetin.

Historical & Cultural Context

Greater Plantain has been used globally in traditional medicine for its expectorant, anti-inflammatory, and wound-healing properties, particularly for treating bronchitis and skin lesions. Historical literature documents its spastic and pain-relieving effects, with local folk use for wounds now validated by modern clinical trials.

Health Benefits

• Respiratory health: Significantly reduces bronchitis symptoms including cough frequency, sputum, and chest pain (strong evidence from RCTs, PMID: 39359439, 7101883)
• Wound healing: Accelerates healing of pressure ulcers, diabetic foot ulcers, and burns (moderate evidence from multiple RCTs, PMID: 33548748, 35044254, 35966146)
• Digestive support: Reduces ulcerative colitis symptoms including abdominal tenderness and pain (moderate evidence from RCT, PMID: 34265576)
• Liver function: Significantly lowers ALT, AST, and triglycerides in NAFLD patients (moderate evidence from RCT, PMID: 31870431)
• Kidney protection: Reduces proteinuria in diabetic nephropathy patients from 165 to 136 mg (moderate evidence from RCT, PMID: 38797623)

How It Works

Aucubin, the primary iridoid glycoside in Plantago major, suppresses NF-κB activation and downstream release of TNF-α, IL-1β, and IL-6, reducing systemic and local inflammation. Acteoside (verbascoside) inhibits protein kinase C and scavenges reactive oxygen species, contributing to antioxidant and immunomodulatory effects at the cellular level. The plant's mucilaginous polysaccharides coat bronchial and gastrointestinal epithelium, physically reducing irritant exposure, slowing mucociliary clearance disruption, and creating a moist microenvironment that facilitates keratinocyte migration during wound healing.

Scientific Research

Multiple randomized controlled trials demonstrate Greater Plantain's efficacy: an 80-patient RCT showed significant bronchitis improvement with 30ml/day syrup (PMID: 39359439), while a 130-patient trial found topical formulation resolved stage 1 pressure ulcers (PMID: 33548748). Additional RCTs confirm benefits for ulcerative colitis (n=61, PMID: 34265576), NAFLD (n=74, PMID: 31870431), and diabetic nephropathy (n=60, PMID: 38797623).

Clinical Summary

A double-blind RCT (PMID: 39359439) demonstrated that standardized Plantago major syrup significantly reduced cough frequency, sputum production, and chest pain in bronchitis patients compared to placebo within 7–14 days of treatment. An earlier controlled trial (PMID: 7101883) corroborated these respiratory findings with measurable improvements in spirometric parameters. Multiple smaller RCTs have reported accelerated closure rates in pressure ulcers, diabetic foot ulcers, and superficial burns when topical Plantago major preparations were applied, though sample sizes in wound-healing studies typically range from 30–80 patients, limiting generalizability. Overall, respiratory evidence is strong (multiple RCTs with consistent outcomes), while wound-healing evidence is moderate and warrants larger confirmatory trials.

Nutritional Profile

Greater Plantain (Plantago major) leaves provide a notable nutritional and phytochemical profile per 100g fresh weight: Macronutrients include approximately 2.5-3.5g protein, 0.3-0.5g fat, 6-8g carbohydrates, and 2.5-3.5g dietary fiber (mix of soluble mucilaginous polysaccharides including arabinogalactans and pectin, and insoluble cellulose). Moisture content is high at ~85-88%. Micronutrients are significant: Vitamin C (~35-50mg/100g fresh leaf, bioavailability moderate, reduced by cooking), Vitamin K1 (~200-300µg/100g, high bioavailability, fat-soluble), Vitamin A activity via beta-carotene (~1500-2000µg RAE/100g), Calcium (~115-130mg/100g), Magnesium (~25-35mg/100g), Potassium (~300-350mg/100g), Iron (~1.2-1.8mg/100g, non-heme, bioavailability enhanced by co-ingested Vitamin C). Key bioactive compounds: Iridoid glycosides — aucubin (0.3-2.5% dry weight, primary active compound, anti-inflammatory via NF-κB inhibition) and catalpol (0.1-0.8% dry weight); Phenylethanoid glycosides — acteoside/verbascoside (0.1-1.5% dry weight, potent antioxidant, ORAC comparable to rosmarinic acid); Flavonoids — luteolin, apigenin, baicalein, and their glucosides (~0.5-1.2% dry weight total); Hydroxycinnamic acids — plantamajoside (~0.2-0.8% dry weight), chlorogenic acid, and neochlorogenic acid; Mucilaginous polysaccharides — plantaglucide (~1-3% dry weight, responsible for gastroprotective and expectorant effects, high bioavailability in GI tract); Tannins — primarily condensed tannins (~2-4% dry weight, astringent, wound-healing relevance); Zinc (~0.4-0.6mg/100g); Silica (~trace, relevant to connective tissue support). Seeds (psyllium-type) contain ~40% mucilaginous fiber. Bioavailability notes: Fat-soluble vitamins (K1, beta-carotene) require dietary fat for absorption; aucubin and acteoside demonstrate good oral bioavailability in rodent models with plasma detection within 30-60 minutes post-ingestion; polyphenols undergo extensive gut microbiota metabolism to bioactive metabolites; iron absorption is limited by co-present tannins unless consumed with ascorbic acid.

Preparation & Dosage

Seeds/powder: 2-4g daily (NAFLD), 3.6g daily roasted seed (ulcerative colitis), or 20g daily powder (diabetic nephropathy). Syrup: 30ml daily for acute bronchitis. Topical: 10% hydroalcoholic extract gel once daily or quercetin-standardized formulation (1.88mg/100g) for wounds. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Marshmallow root, Licorice root, Slippery elm, Quercetin, N-acetylcysteine

Safety & Interactions

Plantago major is generally well tolerated at therapeutic doses; the most commonly reported side effects are mild gastrointestinal discomfort, nausea, and rare allergic skin reactions in individuals sensitive to Plantaginaceae family plants. Because its mucilage can slow gastrointestinal transit and absorption, it may reduce the bioavailability of orally co-administered drugs, particularly anticoagulants like warfarin and digoxin — clinical separation of dosing by at least 1–2 hours is advisable. It exhibits mild diuretic activity and may potentiate the effects of prescription diuretics or blood pressure medications, warranting caution in patients on antihypertensives. Pregnancy and lactation safety has not been established in controlled human studies; traditional use suggests low risk at food-level amounts, but concentrated supplemental doses should be avoided without medical supervision.